BDBM590803 N-(bicyclo[1.1.1]pentan-1-yl)-6-(4-methoxyphenyl)- 1-(2-morpholinoethyl)-2-oxo-1,2-dihydro-1,8- naphthyridine-3-carboxamide::US11564928, Compound 50

SMILES COc1ccc(cc1)-c1cnc2n(CCN3CCOCC3)c(=O)c(cc2c1)C(=O)NC12CC(C1)C2

InChI Key InChIKey=XRWSKQOKSWRNCL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590803   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590803(US11564928, Compound 50 | N-(bicyclo[1.1.1]pentan-...)
Affinity DataIC50: 4.30nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590803(US11564928, Compound 50 | N-(bicyclo[1.1.1]pentan-...)
Affinity DataIC50: 2.78E+3nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent